Clinical Trials
21 trialsNCT06427005 2025-01-22
Fruquintinib Plus S-1 and Raltitrexed (RSF) for MCRC
West China Hospital
Phase 2 Unknown
NCT05774964 2023-03-20
Quintuple Method for Treatment of Multiple Refractory Colorectal Liver Metastases
Liaoning Cancer Hospital & Institute
Phase 2 Unknown
NCT05594381 2022-10-26
A Biomarker Study for Predicting the Efficacy of Neoadjuvant Sintilimab Plus SOX for Gastric Adenocarcinoma.
The First Affiliated Hospital with Nanjing Medical University
Phase 2 Unknown
NCT05529355 2022-09-07
Effect and Safety of Envafolimab Combined With Endostar/S-1 in Second-line of Advanced Non-small Cell Lung Cancer
Anhui Chest Hospital
Phase 2 Unknown
NCT05070598 2021-10-07
Camrelizumab Combined With Chemotherapy in First-line Treatment of HER2-positive Gastric Cancer
Shengjing Hospital
Phase 2 Unknown
NCT03154983 2020-12-09
The Clinical Research of Mesylate Apatinib Combined With Docetaxel and S-1 as the First-line Treatment of Metastatic Gastric Cancer
Zhongnan Hospital
Phase 2 Unknown
NCT04571489 2020-10-01
A Phase II Study of Gimatecan (ST1481) in Locally Advanced or Metastatic Pancreatic Cancer
Lee's Pharmaceutical Limited
Phase 2 Unknown
NCT04216758 2020-06-30
Nab-P and Gem Compared With Gem and Tegafur in Adjuvant Chemotherapy After Radical Resection of Pancreatic Cancer
Fudan University
Phase 2 Unknown
NCT04202484 2019-12-17
Tripletrumab Combined With Oxaliplatin and Teggio (SOX) in First-line Treatment of Gastric and Gastroesophageal Junction Adenocarcinoma
RenJi Hospital
Phase 2 Unknown
NCT03121313 2019-02-12
Maintenance Tegafur-uracil in Resected Oral Cavity Cancer With ECS+
Chang Gung Memorial Hospital
Phase 2 Unknown
NCT03702491 2018-10-11
Apapitatin Combined With SOX for Palliative Adjuvant Chemotherapy in Patients With Advanced Gallbladder Carcinoma
Eastern Hepatobiliary Surgery Hospital
Phase 2 Unknown
NCT03204019 2017-06-29
A Study of Tegafur Combined With Temozolomide Versus Tegafur Combined With Temozolomide and Thalidomide in Subjects With Advanced Pancreatic Neuroendocrine Tumor
ChineseAMS
Phase 2 Unknown
NCT03204032 2017-06-29
A Study of Tegafur Combined With Temozolomide Versus Tegafur Combined With Temozolomide and Thalidomide in Subjects With Advanced Extrapancreatic Neuroendocrine Tumor
ChineseAMS
Phase 2 Unknown
NCT02943252 2016-10-24
The Clinical Study of Apatinib Plus S1 for Patients With Advanced Non-squamous Head and Neck Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Unknown
NCT02623153 2015-12-07
Comparison Between XELOX and S1, Oxaliplatin and Docetaxel as Neoadjuvant Chemotherapy for Gastric Cancer
Shanghai Zhongshan Hospital
Phase 2 Unknown
NCT02280070 2014-10-31
RP II Study of SOX vs mFOLFOX6 in Patients With Resectable Rectal Cancer (KSCC1301).
Clinical Research Support Center Kyush
Phase 2 Unknown
NCT00855881 2011-07-26
Metronomic Chemotherapy With Tegafur/Uracil for Head and Neck Squamous Cell Carcinoma
Mackay Memorial Hospital
Phase 2 Unknown
NCT00890188 2009-05-07
UFUR
National Cheng-Kung University Hospital
Phase 2 Unknown
NCT00384800 2009-02-09
A Phase II Study of Tegafur/Uracil (UFUR®)Plus Thalidomide for the Treatment of Advanced or Metastatic Hepatocellular Carcinoma (HCC)
Far Eastern Memorial Hospital
Phase 2 Unknown
NCT00625352 2008-02-28
Study of Developing an Optimal Gemcitabine Based Regimen to Treat Elderly Patients With Advanced Non-Small Cell Carcinoma
Ulsan University Hospital
Phase 2 Unknown
NCT00037089 2005-06-24
A Phase II Study of Paclitaxel, UFT, and Leucovorin in Patients With Metastatic Esophageal Cancer
Edelman, Martin, M.D.
Phase 2 Unknown